Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA Code

February 7, 2024

https://www.globenewswire.com/news-release/2024/02/07/2825188/8624/en/Trinity-Biotech-Announces-Application-for-Early-Sjogrens-Syndrome-Test-Panel-PLA-Code.html

DUBLIN, Ireland, Feb. 07, 2024 (GLOBE NEWSWIRE) — Trinity Biotech Plc. (Nasdaq:TRIB) (the “Company”) today announced that its New York based reference laboratory, Immco Diagnostics, has applied for a Proprietary Laboratory Analyses (PLA) code for its Early Sjögrens Syndrome Test Panel, to allow for an optimised market access strategy to deliver broader patient access and improved profitability.

Read more at globenewswire.com

Related news for (TRIB)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.